Untitled

Loading Events

« All Webinars

“Adoption of Biosimilars: Key Considerations for Institutions”

Access the recording.

Download a copy of this content.

HealthTrust presents…“Adoption of Biosimilars: Key Considerations for Institutions”

Biosimilars were introduced by Congress through the Biologics, Price Competition and Innovation Act (BPCI Act of 2009) to drive down the costs associated with large molecule biologics. However, 10 years later, increasing the uptake of biosimilars continues to be a challenge due to several factors. This session will review the factors that augment the successful implementation of biosimilars at hospitals and health systems. The speaker will share pertinent background information on biosimilars and how they are produced. From an operational perspective, he will also describe the challenges pharmacies face in making the switch to biosimilars.

Learning Objectives for pharmacists  |  At the end of this session, participants should be able to:

  1. Evaluate the differences between biosimilars and generics
  2. Describe the FDA approval process for biosimilars
  3. Recall the changes made by Centers for Medicare & Medicaid Services (CMS) for the reimbursement of biosimilars
  4. Summarize key considerations for P&T committee members in evaluating biosimilars for formulary inclusion
  5. Explain operational challenges related to implementing biosimilars

Learning Objectives for pharmacist technicians  |  At the end of this session, participants should be able to:

  1. Summarize key considerations for P&T committee members in evaluating biosimilars for formulary inclusion
  2. Explain operational challenges related to implementing biosimilars

Presenter:

Amar Saini, Pharm D  |  PGY-1 Pharmacy Resident  | Atlantic Health System

Target Audience:  Pharmacists and Pharmacy Techs

Continuing Education Information: 1.0 contact hours approved for Pharmacists and Pharmacy Techs. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Numbers for this activity are 0863-9999-19-045-L01-P and 0863-9999-19-045-L01-T. The activity will provide 1 hour (.1 CEUs) of continuing education credit to pharmacists who attend the webinar and complete the online evaluation.

Note about CE credit: If you plan to obtain credit, stay until the end of the presentation to receive the verification code you will need to obtain your continuing education credit. A reminder that CE credit is individual. No group credit is available. Each person must register for this session and attend the webinar for 40 minutes or longer in order to receive an email after the event with instructions on how to apply for continuing education credit. Please do not share the code or forward the email you receive to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. Also, please note: If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.

Effective June 1, 2019: Belmont College of Pharmacy will no longer issue paper/electronic statements of credit for CE activities. ACPE (our accrediting body) policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor at www.nabp.net.

A participant, sponsor, faculty member or other individual wanting to file a grievance with respect to any aspect of a program sponsored or co-sponsored by the Belmont COP may contact the Dean of Belmont University College of Pharmacy in writing at david.gregory@belmont.edu. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.